CI The Cigna Group HOSPITAL & MEDICAL SERVICE PLANS

The Cigna Group (CI) Stock: Buy, Sell, or Hold?

$301.45
-1.68 (-0.55%) â–ŧ
5d: -1.3% 30d: +6.7% 90d: +8.44%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (66%)
Quality Score
52/100
Position
SLIGHTLY HIGH
30-Day Fair Range
$284.39 – $305.85
Position: SLIGHTLY HIGH
Forward P/E & Valuation
9.0x FAIR
vs 8.6x historical avg
Wall Street Target
$342.67
+13.7% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$291.57 / $318.05
Trend: Downtrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
ℹī¸ NEUTRAL: CI is fairly priced but lacks strong directional signals. At 1.8% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
CI is flagged by 1 backtest-validated scanner today

SPY Bullish (stocks from this scanner have beaten SPY by a median 0.37% over the next 20 trading days; CI has been on it 1 day). Backtested on 8 months of scanner history vs the S&P 500, as of 2026-11-11.

See all of today's Best Signals in the free scanner →
Smart Money Accumulation

Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →

Signal fired Oct 30, 2026 at $294.12 · last confirmed Nov 6, 2026

Strength: 5.1/10

Get Alerted When CI Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$392.72
Based on 6.5% avg growth
INTRINSIC VALUE TODAY
$243.85
Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 8.6x Exit PE.

View Full DCF Model

In-depth Analysis How we analyze

Valuation Analysis: CI is currently trading at $301.45, which is considered slightly high relative to its 30-day fair value range of $284.39 to $305.85. The stock's valuation (Forward PE: 9.0) is in line with its historical norms (8.6). At these levels, the market is pricing in 1.8% annual earnings growth.

Technical Outlook: Technically, CI is in a downtrend. Immediate support is located at $291.57, while resistance sits at $318.05.

Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $342.67 (+13.7%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position SLIGHTLY HIGH
Historical Trading Range $284.39 - $305.85
Company Quality Score 52/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 66.2%

Trading Range & Key Levels

30-Day Trading Range $284.39 - $305.85
Current vs Trading Range SLIGHTLY HIGH
Support Level $291.57
Resistance Level $318.05
Current Trend Downtrend
Technical data as of Nov 11, 2026

Protect Your Profits

Holding CI? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

Quantitative Signal Breakdown

  • NEUTRAL: Mixed technical signals (50/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading below Wall St target ($342.67)
  • BULLISH: Expecting earnings turnaround to 1.8% growth with 5.6% revenue growth
  • WARNING: Composite score 52/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) 9.04
Wall Street Target $342.67 (+13.7%)
Revenue Growth (YoY) 5.6%
Earnings Growth (YoY) -21.6%
Profit Margin 2.1%
Valuation Premium vs History +1.8% premium
PE vs Historical 9.0 vs 8.6 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +1.8% (market-implied from PE analysis)
1-Year Target $306.88 (+2%)
2-Year Target $312.40 (+4%)
3-Year Target $318.02 (+6%)
3-Yr Target (if PE normalizes) (PE: 9→9) PE COMPRESSION $302.61 (+0%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 19.9, Growth: 9.0%) $856.89 (+184%)
Base: (SPY PE: 9.0, Growth: 9.0%) $389.96 (+29%)
Bear: (PE: 7.7, Growth: 9.0%) $331.47 (+10%)
📈 Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (13x PE), but valuation improves significantly next year (9x PE) as earnings recover.
Trailing PE: 13.37 | Current EPS (TTM): $22.68
Bull Case $490.36 (+63%)
Analyst growth 47.1%, PE expands to 14.7
Base Case $445.78 (+48%)
Market implied 47.1%, PE stable at 13.4
Bear Case $206.13 (-32%)
Severe decline -20.0%, PE contracts to 11.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share CI Analysis

Share this live CI analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

Reddit StockTwits X / Twitter
bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (CI)

Bullish 2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 12, 2026
Daily AI digest
AI Retail Discussion Summary: Cigna (CI) broke above its 20-day moving average, indicating a short-term bullish trend. The company is currently a Zacks Rank #3 (Hold) stock with positive earnings estimate revisions.
Key Retail Themes: technical analysis earnings estimate revisions
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 7:52 PM ET
Data refreshes hourly during market hours. Next update: 8:52 PM
đŸ”Ĩ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
See Full Scanner Results »
Technical Signals Check

Is CI showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for CI.

Create Free Account

Already have an account? Log In

Top Rated Healthcare Plans Stocks

Top-rated stocks in Healthcare Plans by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
CVS
CVS Health Corp 		STRONG BUY
27 analysts 		$115 55 HOLD
UNH
UnitedHealth Group Incorâ€Ļ 		STRONG BUY
26 analysts 		$477 51 HOLD
ELV
Elevance Health Inc 		BUY
22 analysts 		$482 61 BUY
HUM
Humana Inc 		BUY
26 analysts 		$465 43 HOLD
ALHC
Alignment Healthcare LLC 		BUY
15 analysts 		$11 51 HOLD
CVS CVS Health Corp
55 HOLD
UNH UnitedHealth Grouâ€Ļ
51 HOLD
ELV Elevance Health Iâ€Ļ
61 BUY
HUM Humana Inc
43 HOLD
ALHC Alignment Healthcâ€Ļ
51 HOLD

Advanced CI Option Strategies

Professional options setups generated by AI based on today's CI price and gamma walls.

Iron Condor Bull Call Bear Put Collar

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive CI Research Pages
CI Technical Chart CI Price Prediction CI Intrinsic Value DCF CI Earnings Date Why is CI Moving Today? CI Investment Advisor CI Fair Price Analyzer CI Options Chain CI Options Advisor CI Options Analysis CI Competitors
Part B: Tradestie Flagship Market Scanners
Today's Best Signals (CI) Sector Rotation Monitor AI Supply Chain Money Flow Gamma Squeeze (GEX) Scanner Undervalued Stocks Scanner Insider Cluster Buying Reddit & WSB Sentiment Tracker Backtested Stock Scanner
Compare CI with Peers
CI vs HUM
Which one to buy?
CI vs CNC
Which one to buy?
CI vs HCA
Which one to buy?
CI vs CAH
Which one to buy?
CI vs MCK
Which one to buy?
CI vs UNH
CI vs HUM
CI vs ELV
CI vs CNC
CLOV vs CI
ALHC vs CI
CI vs OSCR
Winner: CI
CI vs MOH
CI vs HCA
THC vs CI
Winner: CI
Create New Comparison View All Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals